Table 1 Patients’ characteristics and surgical outcomes
n% | |
|---|---|
Gender | |
Male | 380 (71.8) |
Female | 149 (28.2) |
Age mean ± SD | 64.9 ± 11.5 |
Body mass index (kg/m2) mean ± SD | 22.9 ± 3.1 |
Comorbidities | 326 (61.6) |
Heart disease | 50 (9.5) |
Ischemic disease | 24 (4.5) |
Arrhythmia | 24 (4.5) |
Congenital cardiac failure | 3 (0.6) |
Others | 7 (1.3) |
CNS disease | 39 (7.4) |
Cerebrovascular disease | 30 (5.7) |
Neurodegenerative disease | 6 (1.1) |
Others | 3 (0.6) |
Liver disease | 21 (4.0) |
Liver cirrhosis | 8 (1.5) |
Chronic hepatitis | 13 (2.4) |
Renal dysfunctiona) | 54 (10.2) |
Pulmonary dysfunction | 124 (23.4) |
Restrictive pulmonary dysfunctionb) | 25 (4.7) |
COPD | 112 (21.2) |
Diabetes mellitus | 67 (12.7) |
Hypertension | 184 (34.8) |
Other disease | 45 (8.5) |
Anemiac) | 131 (24.8) |
Hyoalbuminemiad) | 8 (1.5) |
Type of gastrectomy | |
Total | 78 (14.7) |
Proximal | 34 (6.4) |
Distal | 417 (78.8) |
Extent of LND | |
D1 | 4 (0.8) |
D1+ | 448 (84.7) |
D2 | 77 (14.6) |
Combined resection | 54 (10.2) |
Gallbladder | 39 (7.4) |
Spleen | 13 (2.5) |
Intestine or colon | 2 (0.4) |
Operating time (min) mean ± SD | 287 ± 75 |
Bleeding (g) median (range) | 72 (0 – 2492) |
Pathological tumor stage | |
I | 438 (82.8) |
II | 60 (11.3) |
III | 31 (5.9) |